Cardamyst Spray
Product Images NDC 83468-070

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Cardamyst (NDC 83468-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Milestone Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Car15 0003 01)

FDA Label Image

Figure 1 (Car15 0003 02)

FDA Label Image

Figure 2 (Car15 0003 03)

FDA Label Image

Figure (Car15 0003 04)

FDA Label Image

Figure (Car15 0003 05)

FDA Label Image

Figure (Car15 0003 06)

FDA Label Image

Figure (Car15 0003 07)

FDA Label Image

Figure (Car15 0003 08)

FDA Label Image

Figure (Car15 0003 09)

FDA Label Image

Figure (Car15 0003 10)

FDA Label Image

Figure (Car15 0003 11)

FDA Label Image

Figure (Car15 0003 12)

FDA Label Image

Principal Display Panel – 70 mg Carton Label (Car15 0003 13)

FDA Label Image

Principal Display Panel – 70 mg Device Label (Car15 0003 14)

This is a description of a nasal spray device containing 70 mg of a pharmaceutical solution for intranasal use. The device has a single dose for administration.*

FDA Label Image

Principal Display Panel – 70 mg Container Label (Car15 0003 15)

This is a product description for NDC cardamyst (etripamil) nasal spray devices. Each device delivers two sprays containing a total of 70 mg etripamil. Recommended usage should be seen in the prescribing information provided. The product is for intranasal use only and should be stored at 20°C to 25°C. Instructions for use are enclosed with each package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.